Certified by Founder Lodge
OncoResponse
United States - Seattle, Washington
START UP
1 Disclosed Funding Rounds $14,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad s
Date | Round | Raised | Participating Investors |
---|---|---|---|
May, 19 ,2023 | Unknown | $14,000,000 |